WOODLAND HILLS, Calif.--(BUSINESS WIRE)--EyeArt device shown to be most sensitive automated retinal image analysis technology for diabetic retinopathy screening - rating over 90+% sensitivity across all types of DR - in ARVO study.
Uncategorized